Modeling the costs of hospital-acquired infections in New Zealand

被引:30
|
作者
Graves, N
Nicholls, TM
Morris, AJ
机构
[1] QUT, Sch Publ Hlth, Kelvin Grove, Qld 4059, Australia
[2] Auckland Dist Hlth Board, Infect Control Serv, Auckland, New Zealand
来源
关键词
D O I
10.1086/502192
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE: To model the economic costs of hospital-acquired infections (HAIs) in New Zealand, by type of HAI. DESIGN: Monte Carlo simulation model. SETTING: Auckland District Health Board Hospitals (DHBH), the largest publicly funded hospital group in New Zealand supplying secondary and tertiary services. Costs are also estimated for predicted HAIs in admissions to all hospitals in New Zealand. PATIENTS: All adults admitted to general medical and general surgical services. METHOD: Data on the number of cases of HAI were combined with data on the estimated prolongation of hospital stay due to HAI to produce an estimate of the number of bed days attributable to HAI. A cost per bed day value was applied to provide an estimate of the economic cost. Costs were estimated for predicted infections of the urinary tract, surgical wounds, the lower and cases of multiple sites of infection. Sensitivity analyses were undertaken for input variables. RESULTS: The estimated costs of predicted HAIs in medical and surgical admissions to Auckland DHBH were $10.12 (US $4.56) million and $8.64 (US $3.90) million, respectively. They were $51.35 (US $23.16) million and $85.26 (US $38.47) million, respectively, for medical and surgical admissions to all hospitals in New Zealand. CONCLUSIONS: The method used produces results that are less precise than those of a specifically designed study using primary data collection, but has been applied at a lower cost. The estimated cost of HAIs is substantial, but only a proportion of infections can be avoided. Further work is required to identify the most cost-effective strategies for the prevention of HAI.
引用
收藏
页码:214 / 223
页数:10
相关论文
共 50 条
  • [21] CEFTAZIDIME IN SERIOUS HOSPITAL-ACQUIRED INFECTIONS
    HOOGKAMPKORSTANJE, JAA
    VANERPECUM, KJ
    VANKAMP, H
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 (06) : 743 - 749
  • [22] BACTERIAL ETIOLOGY OF HOSPITAL-ACQUIRED INFECTIONS
    DASCHNER, F
    IMMUNITAT UND INFEKTION, 1984, 12 (03): : 139 - 142
  • [23] Dopamine and the Risk for Hospital-Acquired Infections*
    Murthy, Srinivas
    PEDIATRIC CRITICAL CARE MEDICINE, 2018, 19 (03) : 269 - 270
  • [24] NEWER ANTIBIOTICS AND HOSPITAL-ACQUIRED INFECTIONS
    PULASKI, EJ
    SURGERY, 1970, 67 (02) : 370 - &
  • [25] TREATMENT OF HOSPITAL-ACQUIRED INFECTIONS WITH AMIKACIN
    DOUGHTY, SC
    MARTIN, RR
    GREENBERG, SB
    AMERICAN JOURNAL OF MEDICINE, 1977, 62 (06): : 889 - 893
  • [26] Reporting Biases for Hospital-acquired Infections
    Horowitz, Harold
    AMERICAN JOURNAL OF MEDICINE, 2013, 126 (03): : E27 - E27
  • [27] HOSPITAL-ACQUIRED INFECTIONS: DISCREPANCIES AND OUTCOMES
    Young, Zohdi Cooperrider
    Chavane, Cecile
    Martins, Ines
    Kolls, Brad
    Ohnuma, Tetsu
    Mehta, Sachin
    Wong, An-Kwok
    Barros, Andrew
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [28] Prevalence of hospital-acquired infections in Italy
    Pavia, M
    Bianco, A
    Viggiani, NMA
    Angelillo, IF
    JOURNAL OF HOSPITAL INFECTION, 2000, 44 (02) : 135 - 139
  • [29] THE MANAGEMENT OF HOSPITAL-ACQUIRED STAPHYLOCOCCAL INFECTIONS
    YOW, EM
    YOW, MD
    WOMACK, K
    SAKUMA, T
    MONZON, OT
    ARCHIVES OF INTERNAL MEDICINE, 1958, 102 (06) : 948 - 959
  • [30] The impact of hospital-acquired bloodstream infections
    Wenzel, RP
    Edmond, MB
    EMERGING INFECTIOUS DISEASES, 2001, 7 (02) : 174 - 177